NGS of this tumor specimen was again negative for BRAF, KIT, NF1, and NRAS mutations, but was again notable for a missense mutation in EZH2 (c.2075 C > T, p.A692V) (Table 1). The gene discussed is NRAS; the disease is neoplasm.